PubMed COVID-19 Clinical Care

People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination

Thursday, February 01, 2024 - 4:00 AM

People who use drugs (PWUD) are at a high risk of contracting and developing severe coronavirus disease 2019 (COVID-19) and other infectious diseases due to their lifestyle, comorbidities, and the detrimental effects of opioids on cellular immunity

Direct-to-participant recruitment of mothers and infants: A strategic approach during challenging pandemic times

Thursday, February 01, 2024 - 4:00 AM

Under traditional circumstances, most clinical trials rely on in-person operations to identify, recruit, and enroll study participants and to complete study-related visits. During unusual circumstances, such as the COVID-19 pandemic, the typical

"Being in the digital box". Academic staff experiences in online practical teaching: A qualitative study from six universities and countries

Thursday, February 01, 2024 - 4:00 AM

The COVID-19 pandemic has caused radical changes in education, as in everything else, bringing many challenges. Despite all the difficulties, the COVID-19 pandemic has enormous opportunities for online teaching and the use of digital technologies. A

Invasive mucinous adenocarcinoma of the lung with bronchorrhea - A marked reduction volume of sputum after SARS-CoV-2 infection

Thursday, February 01, 2024 - 4:00 AM

Bronchorrhea is a watery sputum volume of at least 100 mL/day, which is commonly associated with lung malignancies. We report a 57-year-old woman was admitted to the hospital with a cough, profuse sputum. Chest CTs showed crazy paving pattern and

Agent-based social simulations for health crises response: utilising the everyday digital health perspective

Thursday, February 01, 2024 - 4:00 AM

There is increasing recognition of the role that artificial intelligence (AI) systems can play in managing health crises. One such approach, which allows for analysing the potential consequences of different policy interventions is agent-based social

Generation, types and impacts of biomedical waste during COVID-19: Indian context

Thursday, February 01, 2024 - 4:00 AM

India's already-stressed waste disposal system has been strained by the COVID-19 outbreak. The challenge of managing biomedical Waste (BMW) in India has become more complicated in recent years, mainly due to the sudden emergence of COVID-19. As a

Effect of social capital, social support and social network formation on the quality of life of American adults during COVID-19

Thursday, February 01, 2024 - 4:00 AM

This study aims to evaluate the effect of social capital (SC), social support (SS), and social network formation (SNF) on the quality of life of American adults during COVID-19. Using a probability sample of American adults aged 49+, 2370 respondents

Advancing public health informatics during the COVID-19 pandemic: Lessons learned from a public-private partnership with pharmacies

Thursday, February 01, 2024 - 4:00 AM

To support efforts to vaccinate millions of Americans across the United States (US) against COVID-19, the US federal government (USG) launched the Pharmacy Partnership for Long-Term Care Program (PPP) in December 2020 and the Federal Retail Pharmacy

Cognitive dysfunction after covid-19

Thursday, February 01, 2024 - 4:00 AM

No abstract

Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays

Thursday, February 01, 2024 - 4:00 AM

SARS-CoV-2 nsp13 helicase is an essential enzyme for viral replication and a promising target for antiviral drug development. This study compares the double-stranded RNA (dsRNA) unwinding activity of nsp13 and the Omicron nsp13^(R392C) variant, which